{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:20:39Z","timestamp":1791012039358,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1124\/jpet.110.167213","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T02:15:20Z","timestamp":1274926520000},"page":"875-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["In Vivo Pharmacological Characterization of a Novel Selective \u03b17 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease"],"prefix":"10.1016","volume":"334","author":[{"given":"R. Scott","family":"Bitner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Bunnelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla U.","family":"Drescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy L.","family":"Kohlhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Markosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennan C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Nikkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Browman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Radek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Buccafusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.167213_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev.pharmtox.42.082701.145401","article-title":"Molecular psychology: roles for the ERK MAP kinase cascade in memory","volume":"42","author":"Adams","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.110.167213_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1124\/jpet.107.130062","article-title":"[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain","volume":"324","author":"Anderson","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.167213_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.110.167213_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.110.167213_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/neu.10116","article-title":"Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons","volume":"53","author":"Berg","year":"2002","journal-title":"J Neurobiol"},{"issue":"Suppl. 1","key":"10.1124\/jpet.110.167213_bib6","article-title":"Broad spectrum efficacy in cognition by alpha7 neuronal nicotinic receptor activation of the MAP kinase pathway","volume":"9","author":"Bitner","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.110.167213_bib7","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1523\/JNEUROSCI.2444-07.2007","article-title":"Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1\/2 and CREB phosphorylation pathways","volume":"27","author":"Bitner","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.110.167213_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2009.01.069","article-title":"Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo","volume":"1265","author":"Bitner","year":"2009","journal-title":"Brain Res"},{"key":"10.1124\/jpet.110.167213_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2004.02.042","article-title":"Signaling by insulin-like growth factor 1 in brain","volume":"490","author":"Bondy","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.167213_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/JMN:24:1:085","article-title":"Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys","volume":"24","author":"Buccafusco","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.110.167213_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12031-002-0030-6","article-title":"A computer-assisted cognitive test battery for aged monkeys","volume":"19","author":"Buccafusco","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.110.167213_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/pr.108.000562","article-title":"Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection","volume":"61","author":"Buckingham","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.110.167213_bib13","first-page":"299","article-title":"Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury","volume":"20","author":"Chong","year":"2005","journal-title":"Histol Histopathol"},{"key":"10.1124\/jpet.110.167213_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1476-5381.1983.tb09398.x","article-title":"The effects of nicotine on locomotor activity in non-tolerant and tolerant rats","volume":"78","author":"Clarke","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.110.167213_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer's disease","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/jpet.110.167213_bib16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1124\/jpet.110.167213_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2004.09.006","article-title":"Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates","volume":"28","author":"Dalley","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.110.167213_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11065-005-3583-7","article-title":"Working memory and learning in early Alzheimer's disease","volume":"15","author":"Germano","year":"2005","journal-title":"Neuropsychol Rev"},{"key":"10.1124\/jpet.110.167213_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2007-12105","article-title":"One hundred years after the discovery of Alzheimer's disease. A turning point for therapy?","volume":"12","author":"Giacobini","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/jpet.110.167213_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1515\/REVNEURO.2006.17.6.619","article-title":"The role of the extracellular signal-regulated kinase pathway in memory encoding","volume":"17","author":"Giovannini","year":"2006","journal-title":"Rev Neurosci"},{"key":"10.1124\/jpet.110.167213_bib21","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.110.167213_bib22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1471-4159.2008.05483.x","article-title":"Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1\u201342)-induced tau phosphorylation in PC12 cells","volume":"106","author":"Hu","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.167213_bib23","author":"Ji","year":"2007","journal-title":"Abbott Laboratories, assignee. Fused bicycloheterocycle substituted quinuclidine derivatives"},{"key":"10.1124\/jpet.110.167213_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ncl.2007.03.008","article-title":"Alzheimer's disease and mild cognitive impairment","volume":"25","author":"Kelley","year":"2007","journal-title":"Neurol Clin"},{"key":"10.1124\/jpet.110.167213_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","article-title":"A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits","volume":"122","author":"Leiser","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.110.167213_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0163-1047(92)90399-O","article-title":"Persistence of chronic nicotine-induced cognitive facilitation","volume":"58","author":"Levin","year":"1992","journal-title":"Behav Neural Biol"},{"key":"10.1124\/jpet.110.167213_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2008.08.048","article-title":"Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice","volume":"196","author":"Levin","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.110.167213_bib28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1124\/jpet.110.167213_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.110.167072","article-title":"In vitro pharmacological characterization of a novel selective \u03b17 neuronal nicotinic acetylcholine receptor agonist ABT-107","volume":"334","author":"Malysz","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.167213_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.103.061655","article-title":"The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase","volume":"309","author":"Marrero","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.167213_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00702-006-0561-z","article-title":"Nicotinic receptor agonists as neuroprotective\/neurotrophic drugs. Progress in molecular mechanisms","volume":"114","author":"Mudo","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.110.167213_bib32","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.2174\/138161206778792967","article-title":"Molecular and biochemical features in Alzheimer's disease","volume":"12","author":"Pall\u00e0s","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.110.167213_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1124\/jpet.110.167213_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/neu.20223","article-title":"Transcriptional profiling of brain-derived-neurotrophic factor-induced neuronal plasticity: a novel role for nociceptin in hippocampal neurite outgrowth","volume":"66","author":"Ring","year":"2006","journal-title":"J Neurobiol"},{"issue":"Suppl. 1","key":"10.1124\/jpet.110.167213_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2125.1998.0460s1007.x","article-title":"Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses","volume":"46","author":"Rogers","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.167213_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/17425255.1.3.527","article-title":"Donepezil: a review","volume":"1","author":"Seltzer","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.110.167213_bib37","doi-asserted-by":"crossref","first-page":"44920","DOI":"10.1074\/jbc.M204610200","article-title":"Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1\u201342) amyloid","volume":"277","author":"Shaw","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.167213_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF02246215","article-title":"Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats","volume":"117","author":"Stolerman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.110.167213_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-8993(99)01220-2","article-title":"Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type","volume":"824","author":"Yamamoto-Sasaki","year":"1999","journal-title":"Brain Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.167213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:18:09Z","timestamp":1740017889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524459831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0022356524459831"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.167213","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Pharmacological Characterization of a Novel Selective \u03b17 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.167213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}